cancer burden
generation of diagnostics
designed NPs target cancer cells
effective anticancer diagnostics
tumour-homing T cells
different types of cancer
Development of Stimuli
tumour-targeted T lymphocytes
EU institutions
imaging capabilities
responsive drug-loaded NPs
effective nanomedicine products
white blood cells
NP accumulation
carriers of stimuli
Responsive Nanoparticle
personalized medicine
inadequacy of current imaging strategies
anticancer materials compatible
external stimulus triggers NP-release
development of smart cellular nano-machines
industrial processes
tumours
therapy
overarching health problem
extraordinary opportunities
proposed research project endeavours
Fight
unmet medical needs
positive changes
use of nanotechnologies
unbeatable position
industries
lives
injected formulations
strategy
theranostics
work
citizens
competitiveness
results
approach